What are the preferred antiretroviral therapy (ART) regimens for children younger than 3 years with pediatric HIV infection?

Updated: Mar 05, 2020
  • Author: Delia M Rivera, MD; Chief Editor: Russell W Steele, MD  more...
  • Print

Infants exposed to nevirapine in the peripartum period as part of a preventing-mother-to-child-transmission (PMTCT) strategy should not be treated with nevirapine-based combination therapy because of the established higher risk of treatment failure due to nevirapine resistance. Lopinavir/ritonavir-based combination therapy would be the only recommended, preferred initial regimen.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!